Technical Analysis for ACRS - Aclaris Therapeutics, Inc.

Grade Last Price % Change Price Change
B 22.28 5.00% 1.06
ACRS closed up 5.0 percent on Friday, February 26, 2021, on 14 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical ACRS trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Bollinger Band Squeeze Range Contraction 5.00%
BB Squeeze Started Range Contraction 5.00%
1,2,3 Pullback Bullish Bullish Swing Setup 7.79%
Boomer Buy Setup Bullish Swing Setup 7.79%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 7.79%
Inside Day Range Contraction 7.79%
Fell Below 20 DMA Bearish 5.99%
Older End-of-Day Signals for ACRS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Stage Specialty Pharmaceutical Hydrogen Peroxide Topical Medication Common Warts Keratosis

Is ACRS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 25.48
52 Week Low 0.7
Average Volume 3,720,066
200-Day Moving Average 5.55
50-Day Moving Average 14.46
20-Day Moving Average 21.97
10-Day Moving Average 22.40
Average True Range 2.13
ADX 49.63
+DI 27.23
-DI 13.01
Chandelier Exit (Long, 3 ATRs ) 19.08
Chandelier Exit (Short, 3 ATRs ) 22.46
Upper Bollinger Band 24.29
Lower Bollinger Band 19.65
Percent B (%b) 0.57
BandWidth 21.12
MACD Line 1.96
MACD Signal Line 2.63
MACD Histogram -0.6703
Fundamentals Value
Market Cap 956.24 Million
Num Shares 42.9 Million
EPS -4.17
Price-to-Earnings (P/E) Ratio -5.35
Price-to-Sales 25.00
Price-to-Book 3.76
PEG Ratio -0.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.74
Resistance 3 (R3) 26.54 24.85 25.99
Resistance 2 (R2) 24.85 23.72 24.95 25.74
Resistance 1 (R1) 23.57 23.02 24.21 23.77 25.50
Pivot Point 21.88 21.88 22.21 21.98 21.88
Support 1 (S1) 20.60 20.75 21.24 20.80 19.06
Support 2 (S2) 18.91 20.05 19.01 18.82
Support 3 (S3) 17.63 18.91 18.57
Support 4 (S4) 17.83